INARI MEDICAL INC (NARI) Stock Price, Forecast & Analysis
USA - NASDAQ:NARI - US45332Y1091 - Common Stock
NARI Key Statistics, Chart & Performance
The current stock price of NARI is 79.97 USD. In the past month the price increased by 0.53%. In the past year, price increased by 40.08%.
NARI Latest News, Press Relases and Analysis
NARI Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 24.96 | 216.76B | ||
| ISRG | INTUITIVE SURGICAL INC | 63.71 | 196.64B | ||
| BSX | BOSTON SCIENTIFIC CORP | 33.53 | 146.55B | ||
| SYK | STRYKER CORP | 27.16 | 136.74B | ||
| MDT | MEDTRONIC PLC | 16.35 | 115.96B | ||
| IDXX | IDEXX LABORATORIES INC | 57.11 | 57.62B | ||
| BDX | BECTON DICKINSON AND CO | 12.36 | 50.56B | ||
| EW | EDWARDS LIFESCIENCES CORP | 32.23 | 48.64B | ||
| RMD | RESMED INC | 24.77 | 35.79B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 16.47 | 34.52B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 16.91 | 27.03B | ||
| STE | STERIS PLC | 24.64 | 23.95B |
Related stock screener links
About NARI
Company Profile
Inari Medical, Inc. operates as a medical device company. The company is headquartered in Irvine, California and currently employs 1,300 full-time employees. The company went IPO on 2020-05-22. The Company’s products primarily consist of ClotTriever and FlowTriever systems, which are catheter-based mechanical thrombectomy systems that are used for the treatment of the venous thromboembolism (VTE) deep vein thrombosis (DVT), and pulmonary embolism (PE). Its InThrill system is used for the removal of emboli and thrombi from the peripheral vasculature. The LimFlow system is indicated for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and are at risk of major amputation. The company also offers RevCore thrombectomy catheter, which is a thrombectomy device for venous stent thrombosis, Triever 16 Curve catheter, which is used for venous thrombus removal, and ClotTriever Bold catheter, which is used for DVT and the removal of acute and chronic clots in the peripheral vasculature. Its ClotTriever XL, which is a catheter for efficient clot removal with minimal blood loss.
Company Info
INARI MEDICAL INC
6001 Oak Canyon, Suite 100
Irvine CALIFORNIA 92618 US
CEO: William Hoffman
Employees: 1300
Phone: 19499234747
INARI MEDICAL INC / NARI FAQ
What does NARI do?
Inari Medical, Inc. operates as a medical device company. The company is headquartered in Irvine, California and currently employs 1,300 full-time employees. The company went IPO on 2020-05-22. The Company’s products primarily consist of ClotTriever and FlowTriever systems, which are catheter-based mechanical thrombectomy systems that are used for the treatment of the venous thromboembolism (VTE) deep vein thrombosis (DVT), and pulmonary embolism (PE). Its InThrill system is used for the removal of emboli and thrombi from the peripheral vasculature. The LimFlow system is indicated for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and are at risk of major amputation. The company also offers RevCore thrombectomy catheter, which is a thrombectomy device for venous stent thrombosis, Triever 16 Curve catheter, which is used for venous thrombus removal, and ClotTriever Bold catheter, which is used for DVT and the removal of acute and chronic clots in the peripheral vasculature. Its ClotTriever XL, which is a catheter for efficient clot removal with minimal blood loss.
What is the stock price of INARI MEDICAL INC today?
The current stock price of NARI is 79.97 USD. The price increased by 0.05% in the last trading session.
Does NARI stock pay dividends?
NARI does not pay a dividend.
What is the ChartMill technical and fundamental rating of NARI stock?
NARI has a ChartMill Technical rating of 9 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
What sector and industry does INARI MEDICAL INC belong to?
INARI MEDICAL INC (NARI) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
What is the Price/Earnings (PE) ratio of INARI MEDICAL INC (NARI)?
INARI MEDICAL INC (NARI) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.77).
NARI Technical Analysis
ChartMill assigns a technical rating of 9 / 10 to NARI. When comparing the yearly performance of all stocks, NARI is one of the better performing stocks in the market, outperforming 95.58% of all stocks.
NARI Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to NARI. While NARI seems to be doing ok healthwise, there are quite some concerns on its profitability.
NARI Financial Highlights
Over the last trailing twelve months NARI reported a non-GAAP Earnings per Share(EPS) of -0.77. The EPS decreased by -1183.33% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -11.27% | ||
| ROE | -18.07% | ||
| Debt/Equity | 0 |
NARI Forecast & Estimates
22 analysts have analysed NARI and the average price target is 76.99 USD. This implies a price decrease of -3.73% is expected in the next year compared to the current price of 79.97.
For the next year, analysts expect an EPS growth of -2492.94% and a revenue growth 22.24% for NARI